BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
DRD2
,
glucose metabolic process
,
HIV infection
,
Intestine
,
Autoimmunity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
IL 12 p35
Summary
General Info
Curated Studies
Most Correlated Studies
NK cell gene expression in response to activation by mycobacteria of differing virulence
Th1 or Th2 in the presence or absence of TGFbeta
Explore Curated Studies Results
Literature
Most Relevant Literature
Contribution of Interleukin-12A Genotypes to Breast Cancer Risk.
Interleukin-12: Structure, Function, and Its Impact in Colorectal Cancer.
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease.
Signaling pathways underlying TGF-β mediated suppression of IL-12A gene expression in monocytes.
Riboswitch-controlled IL-12 gene therapy reduces hepatocellular cancer in mice.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
IL-10, IL-12 and IL-18 Levels in the Gingival Crevicular Fluid of Patients With Periodontitis and He…
IL-6, IL-17 and IL-35 Levels in the Gingival Crevicular Fluid of Patients With Periodontitis and Hea…
Therapeutic Vaccination in Treated HIV Disease
Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer
A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ